当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 现金流量表

同和药业

(300636)

  

流通市值:32.33亿  总市值:36.96亿
流通股本:3.67亿   总股本:4.20亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金543,433,426.58381,438,529.86164,748,806.02726,747,210.32
  收到的税费返还43,912,759.623,285,732.819,261,405.8139,300,748.14
  收到其他与经营活动有关的现金20,499,825.6916,032,247.446,870,162.71118,345,845.89
  经营活动现金流入小计607,846,011.87420,756,510.11180,880,374.54884,393,804.35
  购买商品、接受劳务支付的现金249,430,115.46181,547,559.2384,863,010.7360,592,517.52
  支付给职工以及为职工支付的现金132,058,780.2288,526,309.9147,401,754.73163,781,567.02
  支付的各项税费5,801,175.474,298,917.482,349,162.1511,554,434.08
  支付其他与经营活动有关的现金27,374,325.5818,568,016.2610,602,191.7463,275,591.34
  经营活动现金流出小计414,664,396.73292,940,802.88145,216,119.32599,204,109.96
  经营活动产生的现金流量净额193,181,615.14127,815,707.2335,664,255.22285,189,694.39
二、投资活动产生的现金流量:
  收回投资收到的现金466,708,181.12366,022,044.183,240,712.3276,676,587.13
  取得投资收益收到的现金144,159.55106,263.77106,263.77683,309.74
  处置固定资产、无形资产和其他长期资产收回的现金净额365,027.45365,027.457,363487,063.16
  投资活动现金流入小计467,217,368.12366,493,335.3283,354,339.0977,846,960.03
  购建固定资产、无形资产和其他长期资产支付的现金282,238,078.23185,032,228.4467,264,490.43136,493,484.14
  投资支付的现金153,337,916.6711,000,000-447,006,409.11
  投资活动现金流出小计435,575,994.9196,032,228.4467,264,490.43583,499,893.25
  投资活动产生的现金流量净额31,641,373.22170,461,106.8816,089,848.66-505,652,933.22
三、筹资活动产生的现金流量:
  取得借款收到的现金348,014,762.13222,580,000164,580,000870,487,338.8
  收到其他与筹资活动有关的现金10,000,00010,000,000-21,000,000
  筹资活动现金流入小计358,014,762.13232,580,000164,580,000891,487,338.8
  偿还债务支付的现金467,120,000302,040,00082,040,000936,259,467.5
  分配股利、利润或偿付利息支付的现金25,823,508.8123,039,781.893,553,457.5829,117,199.49
  支付其他与筹资活动有关的现金14,173,575.613,895,262.9278,312.737,084,425.98
  筹资活动现金流出小计507,117,084.41338,975,044.7985,871,770.281,002,461,092.97
  筹资活动产生的现金流量净额-149,102,322.28-106,395,044.7978,708,229.72-110,973,754.17
四、汇率变动对现金及现金等价物的影响1,405,439.241,613,697.98339,655.944,046,855.02
五、现金及现金等价物净增加额77,126,105.32193,495,467.3130,801,989.54-327,390,137.98
  加:期初现金及现金等价物余额165,412,237.76165,412,237.76165,412,237.76492,802,375.74
  期末现金及现金等价物余额242,538,343.08358,907,705.06296,214,227.3165,412,237.76
补充资料:
  净利润-58,486,512.57-106,584,102.17
  资产减值准备-27,567,589.48-27,880,076.71
  固定资产和投资性房地产折旧-67,063,005.24-113,032,999.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,063,005.24-113,032,999.43
  无形资产摊销-346,466.15-884,218.7
  处置固定资产、无形资产和其他长期资产的损失-194,305.92-1,168,164.38
  公允价值变动损失----49,700
  财务费用-861,276.29-13,173,981.36
  投资损失--13,865.51--574,934.35
  递延所得税-5,595,892.79-5,979,375.71
  其中:递延所得税资产减少-10,059,036.23--41,080,442.07
    递延所得税负债增加--4,463,143.44-47,059,817.78
  存货的减少--4,558,272.49--55,661,084.47
  经营性应收项目的减少--27,409,323.7--12,491,985.34
  经营性应付项目的增加--1,117,328.59-100,716,907.03
  其他-375,015.08--16,301,294.94
  现金的期末余额-358,907,705.06-165,412,237.76
  减:现金的期初余额-165,412,237.76-492,802,375.74
  现金及现金等价物的净增加额-193,495,467.3--327,390,137.98
公告日期2025-10-252025-08-292025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑